html[data-identity='g1'] .g1-header .g1-header-wide .g1-header-layers button { display: none; } html[data-identity='g1'] .g1-header-wide .g1-header-layers a { align-self: center; } html[data-identity='g1'] .g1-header .g1-header-narrow { display: none; } html[data-identity='g1'] .g1-header-nojs { display: none; } @media (width < 721px) { html[data-identity='g1'] .g1-header .g1-header-nojs { display: flex; flex-wrap: wrap; column-gap: 20px; padding: 0 16px 8px; } html[data-identity='g1'] .g1-header-nojs ul { display: flex; gap: 20px; list-style: none; margin: 0; padding: 0; box-shadow: none; } html[data-identity='g1'] .g1-header-nojs a { display: block; padding: 6px 0; font-size: 15px; line-height: 24px; color: var(--ink2); text-decoration: none; } html[data-identity='g1'] .g1-header-nojs a[aria-current='true'] { color: var(--ink); text-decoration: underline 2px var(--ember); text-underline-offset: 6px; } }

PapersPMID:15994258

Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease.

Thorax2005The record ↗

creatine

raisesLean body mass

What moved

1 findingHow to read these marks →

Increases lean body mass
very limitedreplicated ×2
“Creatine increased fat-free mass by 1.09 kg (95% CI 0.43 to 1.74) post loading and 1.62 kg (95% CI 0.47 to 2.77) post rehabilitation.”
Study
RCT
Dose studied
creatine monohydrate 5.7 g with glucose 35 g, three times daily for 2 weeks, then once daily maintenance
Population
Patients with COPD (mean FEV1 46% predicted) taking supplements through 2 weeks of loading and an outpatient pulmonary rehabilitation programme, both arms

Study record

Design: randomised controlled trial
Species: human
Population: Patients with COPD in an outpatient pulmonary rehabilitation programme; creatine monohydrate plus glucose versus glucose polymer placebo (abstract only)
Participants: 38
Comparator: placebo
Duration: not reported
Endpoints measured: 6